sibenadet has been researched along with formoterol fumarate in 3 studies
| Studies (sibenadet) | Trials (sibenadet) | Recent Studies (post-2010) (sibenadet) | Studies (formoterol fumarate) | Trials (formoterol fumarate) | Recent Studies (post-2010) (formoterol fumarate) |
|---|---|---|---|---|---|
| 27 | 7 | 6 | 24 | 0 | 14 |
| Protein | Taxonomy | sibenadet (IC50) | formoterol fumarate (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaraz, L; Bailey, A; Cadogan, E; Christie, J; Connolly, S; Cook, AR; Fisher, AJ; Hill, S; Humphries, A; Ingall, AH; Kane, Z; Paine, S; Pairaudeau, G; Stocks, MJ; Young, A | 1 |
| Alcaraz, L; Bailey, A; Cadogan, E; Connolly, S; Dainty, I; Jewell, R; Jordan, S; Kindon, N; Lawson, M; Lister, A; Mullen, A; Nicholls, D; Paine, S; Pairaudeau, G; Stocks, MJ; Thorne, P; Young, A | 1 |
| Alcaraz, L; Bailey, A; Bonnert, R; Cadogan, E; Christie, J; Connolly, S; Cook, A; Dixon, J; Fisher, A; Flaherty, A; Humphries, A; Ingall, A; Jordan, S; Lawson, M; Mullen, A; Nicholls, D; Paine, S; Pairaudeau, G; Stocks, MJ; Young, A | 1 |
3 other study(ies) available for sibenadet and formoterol fumarate
| Article | Year |
|---|---|
Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonists.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Bronchodilator Agents; Drug Design; Drug Evaluation, Preclinical; Guinea Pigs; Receptors, Adrenergic, beta-2; Structure-Activity Relationship; Thiazoles | 2011 |
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.
Topics: Adrenergic beta-Agonists; Animals; Asthma; Bronchodilator Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Cyclic AMP; Drug Design; Guinea Pigs; Humans; Inhibitory Concentration 50; Models, Chemical; Protein Binding; Pulmonary Disease, Chronic Obstructive; Thiazoles; Time Factors | 2012 |
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.
Topics: | 2014 |